文献速递关节外科运动医学

无超声引导下前路注射是否优于后路治疗肩关节粘连性关节囊炎?一项序贯前瞻性试验

Is the Anterior Injection Approach Without Ultrasound Guidance Superior to the Posterior Approach for Adhesive Capsulitis of the Shoulder? A Sequential, Prospective Trial.
PubMed 文献 · Clin Orthop Relat Res · 2021-01-01

该序贯前瞻性比较研究纳入95例粘连性关节囊炎患者,分别采用后路(以肩峰为标志)和新前路(以肩锁关节为标志)无超声引导注射,结果显示前路准确率94%高于后路78%(OR 0.21,95%CI 0.05-0.83,P=0.03),结论认为新前路注射更准确且可节省超声相关时间与费用。

要点

  • 无超声引导下新前路注射准确率94%,显著高于后路78%(P=0.03)。
  • 前路以肩锁关节为解剖标志,后路以肩峰为标志,均由经验超过10年的肩关节专家操作。
  • 前路准确率接近已发表的超声引导方法,推荐用于关节内注射以节省时间和费用。

核心结论

  • 无超声引导的新前路注射比后路注射更准确,准确率接近既往发表的超声引导方法。
  • 推荐使用新前路进行盂肱关节内注射以替代超声引导注射,节省时间和费用。
  • 新前路的临床效果(焦虑、疼痛、功能结局和不良事件)仍需随机研究 compared with 超声引导注射。

研究设计与样本

  • 序贯、前瞻性、比较研究,2018至2020年治疗108例潜在符合条件的粘连性关节囊炎患者。
  • 排除其他肩部疾病(全层肩袖撕裂和创伤后僵硬)后,95例患者接受注射。
  • 2018-2019年41例(17男24女;平均年龄52±5岁;平均BMI 24±3 kg/m2)接受后路注射。
  • 2019-2020年54例(20男34女;平均年龄54±4岁;平均BMI 23±3 kg/m2)接受新前路注射。
  • 注射由两名经验超过10年的肩关节专家操作,注射含皮质类固醇、局部麻醉剂和造影剂。

主要发现

  • 后路组准确率为78%(32/41),新前路组准确率为94%(51/54)。
  • 两组准确率比较的比值比为0.21(95%CI 0.05-0.83),P=0.03。
  • 准确注射定义为造影剂局限于盂肱关节,不准确为造影剂泄漏至软组织或肩峰下间隙。
  • 注射后20分钟内拍摄X线片,由对技术不知情的放射科医生判定准确性。
  • 所有入组患者均纳入分析。

关键数值与推荐

  • 粘连性关节囊炎临床表现为肩痛加重、病程少于4个月、被动盂肱关节活动度受损且疼痛。
  • 后路注射以肩峰为解剖标志,新前路注射以肩锁关节为解剖标志。
  • 准确注射:造影剂局限于盂肱关节;不准确:造影剂泄漏至软组织或肩峰下间隙。

临床怎么用

  • 对于粘连性关节囊炎,可考虑采用无超声引导的新前路(以肩锁关节为标志)进行盂肱关节内注射。
  • 新前路注射准确率接近超声引导方法,可节省超声相关时间和费用。
  • 临床效果(焦虑、疼痛、功能结局和不良事件)需随机研究进一步比较。

局限性

  • 研究为序贯设计,非随机对照,可能存在时间偏倚。
  • 样本量有限(共95例),且仅由两名经验丰富的专家操作。
  • 未评估临床效果(焦虑、疼痛、功能结局和不良事件),仅以造影剂扩散判定准确性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Shoulder injections for conditions such as adhesive capsulitis are commonly performed and can be administered through image-based or landmark-based injection approaches. Ultrasound-guided injections are widely used and accurate because ultrasound allows real-time visualization of the needle and injected contrast. Landmark-based injections would be advantageous, if they were accurate, because they would save the time and expense associated with ultrasound. However, few prospective studies have compared well-described landmark-based shoulder injection techniques without ultrasound. QUESTION/PURPOSE: Using anatomic landmarks, and without using ultrasound, is the accuracy of glenohumeral injection for adhesive capsulitis greater via the posterior approach or via a new anterior approach? METHODS: Between 2018 and 2020, we treated 108 patients potentially eligible for adhesive capsulitis treatment. These patients had clinical symptoms of aggravating shoulder pain with a duration of less than 4 months and passively impaired, painful glenohumeral ROM. Due to the exclusion of patients with other shoulder conditions (full-thickness rotator cuff ruptures and posttraumatic stiffness), 95 patients received an injection in this sequential, prospective, comparative study. Between 2018 and 2019, 41 patients (17 males and 24 females; mean age 52 ± 5 years; mean BMI 24 ± 3 kg/m2) were injected through the posterior approach, with the acromion as the anatomical landmark, during the first part of the study period. After that, between 2019 and 2020, 54 patients (20 males and 34 females; mean age 54 ± 4 years; mean BMI 23 ± 3 kg/m2) received an injection through a new anterior approach, with the acromioclavicular joint as the anatomic landmark, during the second part of the study period. Injections via both approaches were administered by two experienced shoulder specialists (both with more than 10 years of experience). Both specialists had experience with the posterior approach before this study, and neither had previous training with the new anterior approach. Injections contained a corticosteroid, local anaesthetic, and contrast medium. Radiographs were taken within 20 minutes after the injection, and a radiologist blinded to the technique determined accuracy. Accurate injections were defined as having contrast fluid limited to the glenohumeral joint, while inaccurate injections displayed leakage of contrast fluid into the soft tissue or subacromial space. All of the enrolled patients were analyzed. RESULTS: In the group with the posterior approach, the accuracy was 78% (32 of 41) in contrast to 94% (51 of 54, odds ratio 0.21 [95% CI 0.05 to 0.83]; p = 0.03) in patients with the new anterior approach. CONCLUSION: The new anterior approach without the use of ultrasound was more accurate than the posterior approach. In fact, it was nearly as accurate as previously published ultrasound-guided approaches. We recommend using the new anterior approach for intraarticular glenohumeral injections instead of ultrasound-guided injections because it will save time and costs associated with ultrasound. Still, the clinical effects (anxiety, pain, functional outcome, and adverse events) of the new anterior approach should be compared with ultrasound-guided injections in a randomized study. LEVEL OF EVIDENCE: Level II, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Rijs Z, de Groot PCJ, Zwitser EW, et al. Is the Anterior Injection Approach Without Ultrasound Guidance Superior to the Posterior Approach for Adhesive Capsulitis of the Shoulder? A Sequential, Prospective Trial. Clin Orthop Relat Res. 2021. PMID: 33950868. doi:10.1097/CORR.0000000000001803

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。